Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v11-EN Version v11-EN
Language English English
Date Updated 2017-07-04 2017-07-04
Drug Identification Number 02402831 02402831
Brand name GEMCITABINE INJECTION GEMCITABINE INJECTION
Common or Proper name Gemcitabine Gemcitabine
Company Name PFIZER CANADA ULC PFIZER CANADA ULC
Ingredients GEMCITABINE GEMCITABINE
Strength(s) 38MG 38MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 1 x 52.6mL 1 x 52.6mL
ATC code L01BC L01BC
ATC description ANTIMETABOLITES ANTIMETABOLITES
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-06-01 2017-06-01
Estimated end date 2017-07-03 2017-07-03
Actual end date 2017-07-03 2017-07-03
Shortage status Resolved Resolved
Tier 3 Status No No
Company comments Resolved July 3, 2017. Resolved July 3, 2017.
Health Canada comments